Sign In
Buy EVOK
$11.00
+0 (+0%)
At Close: Mar 16, 2026
FDA Approves Evoke’s GIMOTI™
07:32pm, Friday, 19'th Jun 2020
Commercial Partner EVERSANA Prepares for GIMOTI LaunchEvoke Extends Cash Runway into 2021 SOLANA BEACH, Calif., June 19, 2020 -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty.
The Daily Biotech Pulse: Tiziana Snags A Patent Win, Decision Day For Nabriva And Evoke, IPOs
12:00am, Friday, 19'th Jun 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs June 18)
ADC Therapeutics SA (NYSE:...
The Daily Biotech Pulse: Patent Win For Amarin, FDA Nod For Novartis & Merck, Chembio's Coronavirus EUA Revoked
12:00am, Wednesday, 17'th Jun 2020
Here's a roundup of top developments in the biotech space over the last 24 hour.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs June 16)
ADC Therapeutics SA (NYSE:...
The Week Ahead In Biotech: FDA Decisions In The Cards For Merck, Epizyme, Evoke And Ultragenyx
12:00am, Sunday, 14'th Jun 2020
Biotech stocks came under pressure along with the broader market in the week ended June 12, as a worsening pandemic situation and its impact on the economy led to an across-the-...
Attention Biotech Investors: Mark Your Calendar For June PDUFA Dates
12:00am, Monday, 01'st Jun 2020
Despite the FDA tied up with COVID-19-related activities, May turned out to be a positive month for biopharma companies from the perspective of drug approvals. Three new molecular...
The Daily Biotech Pulse: Cumberland's Positive Anti-Bacterial Readout, FDA Nods For Bristol-Myers, Astellas
11:25am, Wednesday, 27'th May 2020The Daily Biotech Pulse: Mixed Filgotinib Readout For Gilead-Galapagos, Akorn To File For Chapter 11, D-Day For Aquestive
12:00am, Thursday, 21'st May 2020
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech stocks that hit 52-week highs on May 20.)
ADC Therapeutics SA (...
Evoke Receives FDA Conditional Acceptance of Gimoti Brand Name Following NDA Resubmission
12:30pm, Wednesday, 20'th May 2020Evoke Receives FDA Conditional Acceptance of Gimoti Brand Name Following NDA Resubmission
12:30pm, Wednesday, 20'th May 2020
The name Gimoti (pronounced “jye-MOH-tee”) was developed in compliance with FDA’s Guidance for Industry, Contents of a Complete Submission for the Evaluation of Proprietary Names. Based on the
The Daily Biotech Pulse: Aldeyra Jumps Into COVID-19 Drug Fray, FDA Nod For Myriad's Companion Diagnostic Test
12:00am, Wednesday, 20'th May 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs May 19)
ADC Therapeutics SA (NYSE:...
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs May 18)
ADC Therapeutics SA (NYSE:...
Evoke Pharma Reports First Quarter 2020 Financial Results and Changes its 2020 Annual Meeting of Stockholders to a Virtual Format
12:30pm, Tuesday, 12'th May 2020
Gimoti™ Prescription Drug User Fee Act (PDUFA) date is June 19, 2020 SOLANA BEACH, Calif., May 12, 2020 -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical.
